Iptacopan for proteinuria

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 May 2025: Trial registered, NCT06994845
  2. 27 Nov 2025: Trial started, NCT06994845

The trials

NCT06994845: Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

State
Under way
Phase
Phase 3
People
31 planned
Started
27 Nov 2025
Primary completion
28 Jun 2030
Arms
iptacopan
Results
None posted
  1. 29 May 2025: Trial registered
  2. 27 Nov 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.